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Abstract
Background: Randomized trials have long been the gold-standard for evaluating clinical practice. There is
growing recognition that rigorous studies are similarly needed to assess the effects of policy. However, these
studies are rarely conducted. We report on the Quality Improvement Demonstration Study (QIDS), an example
of a large randomized policy experiment, introduced and conducted in a scientific manner to evaluate the impact
of large-scale governmental policy interventions.
Methods: In 1999 the Philippine government proposed sweeping reforms in the National Health Sector Reform
Agenda. We recognized the unique opportunity to conduct a social experiment. Our ongoing goal has been to
generate results that inform health policy. Early on we concentrated on developing a multi-institutional
collaborative effort. The QIDS team then developed hypotheses that specifically evaluated the impact of two
policy reforms on both the delivery of care and long-term health status in children. We formed an experimental
design by randomizing matched blocks of three communities into one of the two policy interventions plus a
control group. Based on the reform agenda, one arm of the experiment provided expanded insurance coverage
for children; the other introduced performance-based payments to hospitals and physicians. Data were collected
in household, hospital-based patient exit, and facility surveys, as well as clinical vignettes, which were used to
assess physician practice. Delivery of s e r v i c e s  a n d  h e a l t h  s t a t u s  w e r e  evaluated at baseline and after the
interventions were put in place using difference-in-difference estimation.
Results:  We found and addressed numerous challenges conducting this study, namely: formalizing the
experimental design using the existing health infrastructure; securing funding to do research coincident with the
policy reforms; recognizing biases and designing the study to account for these; putting in place a broad data
collection effort to account for unanticipated findings; introducing sustainable policy interventions based on the
reform agenda; and providing results in real-time to policy makers through a combination of venues.
Conclusion: QIDS demonstrates that a large, prospective, randomized controlled policy experiment can be
successfully implemented at a national level as part of sectoral reform. While we believe policy experiments
should be used to generate evidence-based health policy, to do this requires opportunity and trust, strong
collaborative relationships, and timing. This study nurtures the growing attitude that translation of scientific
findings from the bedside to the community can be done successfully and that we should raise the bar on project
evaluation and the policy-making process.
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Background
While clinical interventions are typically grounded in sci-
entific evidence before widespread adoption, public poli-
cies are not typically subjected to the same scientific rigor
[1,2]. By definition public policies are made to affect
whole populations [3]. This alone is a compelling reason
to be judicious and well-informed before implementing
new policy. The sheer costs of maligned policy add further
to the gravity of choosing unwisely. Arguably, therefore,
policy interventions should be put through the same level
of caution and consideration as clinical trials, which do
not nearly have the same scope or reach of social policies
[4]. Increasingly, there is greater credence given to this
argument and there is growing demand that decision-
making in the policy environment be science-based
[1,2,5-7].
There are a variety of scientific approaches for generating
and finding the best evidence for diagnosing and treating
disease, with the standard being the randomized clinical
trial (RCT). In an RCT, the link between clinical care and
health outcomes is often more direct than with policy
change, thus causality is more readily evaluated and, for
the most part, more easily measured. Generating rand-
omized policy trials is more challenging in several impor-
tant ways. Policy interventions can be difficult to
randomize among populations, and challenges will arise
when trying to time the introduction of interventions so
that proper pre- and post- assessments are completed;
similarly, measuring outcomes of interest is not trivial–
collecting data of high caliber can not only be costly but
often a significant lag time is required before population
changes are seen. Additionally, interventions are rarely
introduced devoid of political context, making it all the
more difficult to separate science from the often conten-
tious and fractious political environment. Perhaps one of
the biggest limitations, however, is that policy interven-
tions are often assumed to be effective when there is scant
evidence that they are and, as a result, they are not even
considered to be worthy of scientific investigation.
The Philippine Child Health and Policy Experiment, also
known as the Quality Improvement Demonstration Study
(QIDS), is a unique example of how a large randomized
control longitudinal study can be introduced in a rigorous
scientific manner to evaluate the impact of governmental
policy interventions. In this paper, we describe how we
were able to conduct a prospective randomized policy
experiment, the lessons learned, and the few obstacles
that remain.
Methods
Setting for the experiment
The Philippines Department of Health (DOH) took a
major step towards improving the performance of the
health sector in 1999 by launching the National Health
Sector Reform Agenda (HSRA) to change the way health
services were being financed and administered. The
reform policies were directed mainly at a) increasing
access to personal health services, especially for the poor,
and b) improving the quality of care delivered at hospi-
tals.
Institutions
The Philippines Department of Health is the principal
government agency that formulates national health poli-
cies and programs, and guides the development of local
health systems, programs, and services. The DOH is led by
the Secretary of Health, who is appointed by the Presi-
dent. An institution attached to the DOH, the Philippine
Health Insurance Corporation (PhilHealth) is the govern-
mental financial institution implementing the National
Health Insurance Program, making it the largest insurance
carrier in the Philippines. Mandated by the National
Health Insurance Law of 1995, PhilHealth's priorities are
to achieve universal coverage, expand insurance benefits,
and ensure high quality of care and member satisfaction.
The National Health Insurance Program covers employees
from the formal sector, retirees and pensioners, self-
employed individually paying individuals, and the poor.
PhilHealth reimburses on a first-peso basis payment for
inpatient services including room and board, surgical pro-
cedures, physician services, selected diagnostic and treat-
ment procedures, and drugs. In 2006, PhilHealth had an
estimated active membership coverage of 16 million
members with more than 68 million beneficiaries, thus
covering about 79% of the estimated 86.9 million in the
entire country.
PhilHealth, however, has faced challenges in reaching
their goals of universal coverage and improved health care
delivery [8]. Recognizing that the ultimate success of
reform policies lies in the understanding of how they
affect the quality of health care provided to those in need
and whether these changes have beneficial effects on
health, 10 years ago PhilHealth committed itself to the
financing and implementation of health reform policies
targeted at improving health care for children and the
poor.
The poor, also referred to as indigents in the Philippines,
largely depend on the public health system, which is
made up of government hospitals, rural health units, and
local barangay health stations. About 40% of all hospitals
in the Philippines are public and contribute to over half of
all beds in the country [9]. Provincial governments main-
tain large provincial and district hospitals while munici-
pal governments are in charge of rural health units and
barangay health stations, which are primary health-care
facilities. PhilHealth covers costs of qualified public andHealth Research Policy and Systems 2008, 6:5 http://www.health-policy-systems.com/content/6/1/5
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private health services for indigent members through Phil-
Health's Sponsored Program. In 2006 there were close to
5 million indigent families, or 25 million individuals,
enrolled in this program.
The Visayas and health status of children in the region
While the National Health Sector Agenda was intended to
be implemented nationwide, the DOH designated the
Visayas, one of the three major island groups, as the site
for QIDS implementation. The Visayan islands cover
about one-third of the geographical area of the entire
country. A main advantage of the Visayas in this study is
the geographic isolation of many island sites, limiting
cross-over of people between intervention sites. As most
of the Visayas is rural, many of its residents are poor and
depend on farming and fishing as their source of income
[10,11]. Children in such rural areas of the Philippines
have a high burden of disease. According to the 2003
National Demographic and Health Survey conducted by
the Philippines Department of Health, infant mortality is
24 deaths per 1,000 for urban areas and 36 deaths per
1,000 in rural areas [12]. The national mortality rate for
children under age 5 is 30 per 1,000 for urban areas and
52 per 1,000 in rural areas. From 2000 to 2003, diarrheal
disease and pneumonia accounted for 25% of all deaths
among children under age 5 [13]. Approximately 12% of
children in rural areas have symptoms of acute respiratory
illness, but only 43% of them were taken to a health facil-
ity or provider for treatment. Among those with diarrhea,
only 29% were taken to a health facility or provider. Data
from the 6th National Nutrition Survey reveal that 30% of
Filipino children under age 5 are stunted (less than 2
standard deviations (SD) below the mean height for age),
27% are underweight (less than 2 SD below the mean
weight for age) and 5.3% are wasted (less than 2 SD below
the mean weight for height) [14].
Results
To implement a social policy experiment required that we
first recognize the research opportunity in a complex envi-
ronment surrounded with scientific, bureaucratic and eco-
nomic pressures. However, this, we found, was just the
beginning. Establishing the scientific basis for evaluating
policy, overcoming the unique challenges of randomiza-
tion, carrying out the policy interventions and collecting
community level data are all key elements that, in our
experience, distinguished both the challenge of conduct-
ing a social experiment and the integrity of a policy exper-
iment from clinical trials and other evaluation efforts.
Herein we describe the vital factors that led to the success-
ful implementation of the QIDS social policy experiment.
Success in establishing QIDS – recognizing opportunity
At the outset, we realized two important facts about the
broad reform agenda in the Philippines. The first was,
despite global interest in health sector reform, there was
little scientific information on the effectiveness of even
the most basic reform policies considered in the Philip-
pines and other parts of the world. In this case, there was
a dearth of compelling evidence to show that increasing
insurance coverage leads to improved health status in
populations and an international debate over the benefits
of pay-for-performance. Second, the Philippines govern-
ment lacked the financial resources for a national roll-out
of either proposed reform policies. The scientific uncer-
tainty of the effectiveness of either policy, coupled with
the practical problem of financing a large-scale introduc-
tion of the policies, was the opportunity that we recog-
nized for putting a policy experiment in place.
Though conceived and spearheaded by Dr. Peabody of the
Institute for Global Health at University of California San
Francisco (UCSF) and Dr. Solon of the UPecon Founda-
tion based at the University of the Philippines School of
Economics, QIDS was designed in close relationship with
the DOH and PhilHealth. We discussed at length, for
example, the opportunity for a scientific study beginning
with the then Secretary of Health, Dr. Alberto Romualdez.
The DOH, recognizing the unique opportunities around
informing policy and establishing global solidarity,
brought PhilHealth into the discussion from the start, giv-
ing them a central role since PhilHealth is the payer for the
national health insurance program and the institution
that could best implement these reform policies. Through
these discussions, a new type of collaborative was formed.
We then linked the two broad HSRA reform goals–
increasing access and improving quality–with the
detailed, specific hypothesis-driven interventions and
their experimental introduction.
Funding and timing of the study
Funding is a ubiquitous issue particularly in health policy
research where the costs are high and the need for action
urgent. We had two main sources of funds: First, Phil-
Health committed and maintained a financial obligation
to the QIDS experiment by funding the actual policy inter-
ventions. This funding, although relatively modest, was
critical to the overall credibility of the study. For the scien-
tific efforts–ones that fall outside of most implementing
agencies purview, we had to turn to outside sources. In the
Philippines, or most other developing countries, there is
no tradition of funding scientific research, thus external
funding from international sources was pursued. We
sought research money from the U.S. National Institutes
for Health (NIH). Securing funds for the full 5-year study,
however, proved to be a challenge, particularly given the
highly competitive environment at the NIH. Concerns
raised included the uncertainty in successfully carrying
out such a large experiment requiring coordination with
the government and the value of the study's findings out-Health Research Policy and Systems 2008, 6:5 http://www.health-policy-systems.com/content/6/1/5
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side of the Philippines. In due course, we successfully
obtained an R01 grant from the National Institute of
Child Health and Human Development (NICHD) for the
5-year study (R01-HDO42117), making the argument
that the effects of pay-for-performance, which was under-
going a similar renaissance in the U.S., and universal cov-
erage, being pursued through initiatives such as the State
Children's Health Insurance Program, were poorly under-
stood.
A related and formidable challenge was to time the intro-
duction of the official policies with the arrival of the
research funding. Our rigorous design required  that we
conduct a pre- and post-intervention assessment around
the outcomes of interest. We timed the grant application
to follow policy approval but to precede policy imple-
mentation. In part this was due to good planning and
coordination with our partners at DOH and PhilHealth.
Thus, while announcements were made early on, imple-
mentation was more flexible and could, in this case, be
accelerated to meet our research funding schedule.
Formalizing the experiment into the legal and regulatory 
systems
The policy environment from a methodical, scientific per-
spective is uncertain and fraught with unplanned events.
In other policy reform settings, we had observed an eva-
nescent enthusiasm accompanying research activities that,
in the day-to-day context of institutional operations,
would dissipate. Recognizing these realities we sought to
minimize their impact. We thus obtained legislative and
regulatory sign-off that codified the integration of the
experimental design directly into the existing infrastruc-
ture. Specifically, QIDS did this early on by creating several
formal partnerships–provincial, local and national–for the
experiment. For the provincial partnerships, we executed
legally binding Memorandums of Agreement (MOAs). To
obtain buy-in at the local level, we extended these commit-
ments down to the 30 participating local government units
in the participating provinces, through additional MOAs
obtained prior to site randomization. Once these agree-
ments were signed, we vetted QIDS a second time with the
national government (PhilHealth) and requested formal
resolutions from the PhilHealth Executive Board.
To further minimize external events, PhilHealth played an
operational role, both centrally and regionally, to imple-
ment the study. Through the partnership, the central
office designated formal budget administrative responsi-
bilities and the regional staff explicitly collaborated at the
ground-level to implement the policy interventions,
administer the clinical vignettes (which assessed the qual-
ity of care), disbursed the bonus payments, conducted
some of the intervening data collection, and monitored
insurance coverage levels.
Randomizing the policies and controlling for experimental 
biases
In the Philippines, there are 220 districts, with an average
population size of 250,000. Since the interventions were
to be implemented at the provincial district level, an
administrative unit that manages the delivery of health
and other social services, we needed to randomize the
experimental design to this level of the community. The
two policy interventions, including controls, were thus
randomly assigned to the 30 districts situated in the 11
provinces in the Visayas.
Randomization, proved to be complex, because there was
an a priori assumption made by communities that partic-
ipation in the study meant receiving a new policy with
new resources. Accordingly, after the sites were identified,
the study team held a series of meetings with government
officials, provincial governors, provincial and municipal
health officers, regional PhilHealth officers and the may-
ors (who were the heads of municipalities or cities), to
seek their voluntarily consent to participate in the rand-
omization and to provide them with the operational
details pertaining to the implementation of policies and
data collection.
We grouped districts with similar population characteris-
tics into matched blocks of three before randomizing. The
group characteristics, obtained from national census and
local data, included population size, average income,
labor force participation rate, functional literacy, infant
mortality rate, maternal mortality rate, percentage of the
population with insurance, proportion of the population
that is rural, and proximity to Manila. To minimize
within-block variation for each characteristic, the
matched locations had to be within 10 to 25% of the exist-
ing variation. Randomization was then done among the
matched blocks, with one site randomly chosen as an 'A'
site, one as a 'B' site, and the third as a control or 'C' site,
which are described in more detail below.
Because of the possibility that the study itself may alter the
behavior response of the participants over time, careful
consideration was given to control for potential participa-
tion effects in the study design. Because the study called
for an evaluation of physician practice and children's
health status for two clinical conditions, one effect might
be that doctors change their practice patterns for the dis-
eases in question. To overcome this, we selected or
"screened-in" children who had been admitted with
diarrhea or pneumonia. Screened-in children were identi-
fied as the subset of patients to be followed longitudi-
nally. We also sampled children who were admitted for
conditions other than diarrhea and pneumonia, or
"screened-out". If there was a participation effect of the
doctors, we would be able to measure it by comparing rel-Health Research Policy and Systems 2008, 6:5 http://www.health-policy-systems.com/content/6/1/5
Page 5 of 12
(page number not for citation purposes)
ative changes over time. Another potential participation
bias was due to patient selection, wherein there might be
substantive differences between children who came to the
hospital versus the general population. We thus included
a population-based survey of random households from
the catchment areas surrounding QIDS hospitals.
QIDS interventions
When we developed the policy interventions for the study,
naturally, we wanted them to be linked closely to the areas
that corresponded to the primary HSRA reforms. Our
explicit task was to tie well-defined hypothesis-driven
interventions to the actual HSRA policies aimed at
improving health care access to the poor and increasing
the quality of care. QIDS thus introduced expanded Phil-
Health membership to children under 6 years of age and
then measured changes in utilization of all services. We
call this the Access Intervention carried out in the 'A' sites.
PhilHealth membership in the A sites was made available
at no cost to all indigent children under the age of 6 years
and their families. In addition, this scheme typically
results in 100% financial coverage for ordinary cases such
as pneumonia and diarrhea; if charges exceed the PHIC
benefit limits, they are shouldered by the local govern-
ment unit hospital.
The second policy, a supply-side intervention, targeted
physicians by introducing financial incentives for doctors
providing high quality care, which is in essence a pay-for-
performance scheme. We call this the Bonus Intervention,
carried out in 'B' sites. Physicians in the district hospitals
randomized to the B sites had to meet quality standards,
which were pre-determined, to be eligible for bonus pay-
ments. We used a measurement standard of quality,
referred to as Q*, wherein we combined an average of
clinical vignette scores, which measured the quality of
clinical care of doctors caring for patients with diarrhea
and pneumonia, with a measure of facility case load, and
a measure of patient satisfaction [15]. Each quarter, the
QIDS Q* metric is computed from randomly selected
physicians for each hospital assigned to this intervention
and official PhilHealth issuances are made to hospitals
indicating whether or not it is qualified to receive bonus
payments. The bonus amount is calculated quarterly for
qualifying hospitals and distributed to all clinical staff,
with half going to the physicians, and the remaining half
divided between nurses, administrators and support staff.
Longitudinal and multi-level assessment of health 
determinants and outcomes
Data collection presented two distinct challenges relative
to evidence generation: timeliness and comprehensive-
ness. We conducted a baseline, or pre-intervention, evalu-
ation of study facilities and participants. Smaller data
collection efforts were carried out at various intervals after
the introduction of the policy interventions followed by a
second major round of data collection after approxi-
mately two years. With these pre- and post-intervention
assessments, we are able to observe transition states over
time and other changes in variables of interest not possi-
ble from a cross-sectional study; this design also allows
the control for otherwise-omitted variation in outcomes
among individuals [16]. Our design and related data col-
lection allow us to measure the impact of the policy inter-
ventions on outcomes of interest using difference-in-
difference estimators, which we use to compare the
changes (before and after intervention) in the outcomes
in intervention sites with the corresponding changes in con-
trol sites. By looking at the changes over time we control
for individual and area-specific characteristics and secular
trends that might confound the estimated policy impact.
The second challenge to data collection was ensuring that
we captured all changes, not just the outcomes of interest
that might occur as a result of the policy interventions.
Given the potential of the policy interventions to change
provider and patient behaviors and outcomes, facilities
and physicians, patients and their households were all
included in the assessments. Figure 1 illustrates the multi-
level nature of the study as well as its longitudinal design,
which we briefly describe below.
The comprehensive data collection started with QIDS hos-
pitals and physicians, surveyed on a semestral basis and
on a quarterly basis respectively, giving numerous data
points for longitudinal study. At each facility, structural
measures, such as the availability of electricity and sanita-
tion, overall cleanliness, qualified staff, organization of
services, drugs, and equipment, were collected. However,
while structural measures are necessary to monitor certain
aspects of quality, they are insufficient indicators of care
provision. Thus to assess the quality of care and accurately
measure the patient-provider interaction, we used clinical
vignettes. Vignettes, written case scenarios which simulate
patient visits and are followed by questions for doctors to
answer, are used as an accurate, affordable, and valid
measure of a doctor's ability to evaluate, diagnose, and
treat specific conditions [17-19]. Table 1 outlines the
measures used at each assessment.
Children at the QIDS sites were enrolled into the study
upon hospital discharge, and extensive health assess-
ments, including blood tests and subjective health assess-
ments, were made at this visit, which we called the Patient
Exit assessment. Our two tracer conditions, diarrhea and
pneumonia, identified the subset of patients to be fol-
lowed longitudinally. By examining a specific health
problem or process, tracer conditions allowed us to focus
on the impact of the policies on these particular condi-
tions. Children screened-in with the tracer conditionsHealth Research Policy and Systems 2008, 6:5 http://www.health-policy-systems.com/content/6/1/5
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were followed home 4 to 10 weeks post hospital dis-
charge. Apart from detailed information on the house-
hold, blood, subjective health, and cognitive data were
also collected during this home visit, which we called the
Follow-Home Household assessment. These same
patients were then followed two years after the initial hos-
pital visit for another assessment of health and cognitive
status in the Panel Household survey.
Data collection team and data quality
Because of its breadth, QIDS required a large, well-quali-
fied multidisciplinary data collection team. Accordingly,
in each of the 11 study provinces QIDS assigned a team of
three medical technologists, two psychologists and one
supervisor. Supervisors are responsible for the timeliness
and rigor of data collection and ensure that all eligible
children are asked to participate, the survey visits are
scheduled on time, facilitate team logistics and timely
delivery of the biomarkers. Three regional program man-
agers oversee the supervisors in the 11 provinces address-
ing concerns and issues raised by the field staff. Finally,
central staff, consisting of a survey leader, a program man-
ager, research assistants, and a data entry team, contribute
to a data collection process that is efficient, on-time, and
available.
As a result, QIDS has a high response rates for both initial
and continued participation. In both rounds of data col-
lection only about 10% of eligible participants refused to
take part in the study. Of those who agreed to participate
in the study, 0.5% refused at the time of the follow-home
household survey. The refusal rate for panel children who
were initially surveyed two years earlier was 1.5%. And
between the two rounds of data collection less than 1% of
children were lost to follow-up.
Inter-current use of the QIDS data
A common, and valid, criticism of policy research is that
results are not timely and accordingly often not relevant to
policy-makers where the study is being conducted [20]. To
Multi-level data collection in the Quality Improvement Demonstration Study Figure 1
Multi-level data collection in the Quality Improvement Demonstration Study.Health Research Policy and Systems 2008, 6:5 http://www.health-policy-systems.com/content/6/1/5
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overcome this concern, we conceived of using QIDS data
to guide government initiatives in real-time. In 2006, for
example, the original 1997 HSRA implementation strat-
egy was revised under a new administration and called
FOURmula One (F1) for Health. We did some analyses
from the first round of QIDS that led to shifting the focus
of F1 towards increasing PhilHealth enrollment, quality
of care, and no-balance insurance billing. More recently,
in 2007, the QIDS methodology and data were again crit-
ical inputs for the DOH in designing the Monitoring and
Evaluation of the F1 agenda. QIDS analyses have also
formed the basis for bilateral assistance from USAID,
whose goal is to strengthen and institutionalize policy
evaluation and coordinated policy reform. The QIDS
framework has been used by the Philippine Government
to demand impact evaluation for a host of other bilateral
and multilateral projects the country. QIDS also produces
policy briefs, published three to four times a year, to
update the policy community on policy-relevant analysis.
QIDS data are publicly available. All non-identifiable data
along with questionnaires and data codebooks are in the
public domain and available on the Internet [21]. The
QIDS website also serves as a repository of findings from
completed analyses.
Discussion
This paper reports on the successful implementation of
QIDS, a large policy experiment in the Philippines. We
argue that policy should be evidence-based and thus there
ought to be a strong interest in making the policy environ-
ment more amenable to scientific analyses. QIDS demon-
strates that with a scientific framework, collaboration and
coordination, opportunistic insights and some serendip-
ity, large-scale policy experiments can be conducted.
Below, we first discuss the importance of bringing evi-
dence into policy making and its major challenges. Then
we show how the lessons learned from QIDS might
advance our collective experience with policy experiments
and integrated science-based policy making. We conclude
with a discussion on our limitations.
Integrating evidence into policy making
Experience suggests that policy-making is typically devoid
of scientific evidence and frequently not even supported
by anecdotal evidence [22]. The evidence-base for poli-
cies, both inside and outside the health sector, is certainly
weak when compared to evidence required for decision
making in other areas, such as clinical medicine. This is
often attributed to the complex nature of the policy envi-
ronment [23,24]. First among these complexities is the
breadth of social policies that, by nature, affect individu-
als and communities as a whole through a variety of dis-
parate pathways [25]. Modeling or quantifying the
impacts of these broad policies is necessarily a challenge.
For instance, even more focused health policies are rarely
evaluated because of the difficulties in monitoring and
Table 1: Summary of Measures Collected for QIDS Assessments of Patients, Households, Physicians and Facilities
Household Survey
Measure Facility Survey Patient Exit Survey Follow-home Panel
Quality of Care
Clinical Vignettes X
Structural survey of facility X
Patient Response
Utilization and cost XX X
Service characteristics XX X
Demographics
SES XX X
Expenditures and charges XX X
Home Observation and Measurement of the Environment (HOME) X X
Subjective Health
General Self Reported Health X X X
Objective Health
Anthropometrics XX X
Blood screening:
Lead XX
Hemoglobin XX X
Folate XX
C-reactive protein XX X
Cognitive Development
Bayley Scales of Infant Development XX
Wechsler Preschool and Primary Scales of Intelligence X XHealth Research Policy and Systems 2008, 6:5 http://www.health-policy-systems.com/content/6/1/5
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evaluating multiple activities, the challenges of observing
disparate effects, or because there has been too little time
to observe meaningful changes. Secondly, the "politics" of
policy-making make for an environment where decision-
makers are less interested in science, health impact or
effectiveness, and more concerned with electoral interests,
financial implications, and views of particular communi-
ties or groups. A related barrier to evidence-based policy-
making are structural barriers to communication between
researchers and decision makers, which include "differ-
ences in priorities, language, means of communication,
integration of findings and definition of the final product
of research" [4].
Despite the challenges to evidence-based policy making,
the fact remains that governments need to know at the
outset of policy development, and after policies have been
implemented, the likely and achieved impacts in terms of
both the positive and negative outcomes. The most rigor-
ous way of monitoring the impact of an intervention or
program, when feasible, is using a randomized controlled
design, which assesses the impact of a policy by exposing
a group of people to the policy intervention of interest at
random while withholding the policy to a control group
[16]. Baseline data are collected prior to the introduction
of the policy, and again at an appropriately determined
follow-up time. The differences between the measure-
ments at baseline and follow-up estimate the net effect of
the policy of interest, assuming proper randomization
and large enough sample size to identify a minimum
detectable effect [16]. Randomizing policies to whole
communities, securing the units of analysis, maintaining
internal consistency, timing the interventions with data
collection, ensuring high quality data, and the inherently
political nature of the evaluation process are all unique to
the social experimental setting.
A notable example of a randomized policy study that
arose from a governmental sponsored social investment
in evidence-based policy is PROGRESA or Oportunidades
in Mexico. Like QIDS, PROGRESA, was a major govern-
ment initiative; aimed at reducing long-existing poverty
and developing human capital within poor households
[26]. Introduced in 1997, this was the first national con-
trolled randomized anti-poverty intervention program in
a developing country [27]. The intervention offered con-
ditional cash transfers in order to promote incentives for
positive behavior, such as participation in health and
nutrition programs, including prenatal care, immuniza-
tion, and nutrition supplementation, and provided incen-
tives to promote children's school attendance.
Communities were also randomly phased into treatment,
allowing researchers to identify the impact of transfers on
a variety of child health and educational outcomes. A key
feature of the program was the opportunistic series of rig-
orous impact evaluations. While PROGRESA evaluations
are considered some of the most expensive ever intro-
duced by the government, they have been internationally
acknowledged as being an invaluable source of data for
governments in guiding policy decisions [28]. PROGRESA
has subsequently expanded into the ongoing Oportuni-
dades Program, which continues the evaluation practice.
Similar to the experiences with PROGRESA, QIDS under-
scores the feasibility and value of studying policy inter-
ventions in a scientifically rigorous fashion and then
using these data for large sector governmental changes in
a systematic and integrated fashion.
Lessons learned
Some of the lessons learned from QIDS might guide
future research, help avoid pitfalls and foster interest in
evidence-based policy research. We list here seven of the
most important lessons we learned that formed the foun-
dation of our work: 1) recognizing opportunity and form-
ing a multi-institutional collaboration, 2) identifying and
securing funding and timing the study with policy
changes, 3) formalizing the study, 4) randomizing the
policies and controlling for potential biases, 5) introduc-
ing sustainable policy interventions, 6) collecting compre-
hensive data, and 7) using results to inform policy-
making in real-time. Those that are more complex are
described in more detail below.
First, we found opportunity in the Philippines health
reform process in the scientific uncertainty surrounding
the effectiveness of the policies in question. Since few pol-
icies have been scientifically validated, there are likely
many opportunities to be found to assess health impacts
[25]. Although there is always serendipity around oppor-
tunity, policy analysis lends itself to opportunistic evalua-
tions if for no other reason than this dearth of scientific
data.
The insight, we feel, is to be able to recognize opportunity
and then be prepared to act on it in timely manner, which
requires experience in the policy environment, relation-
ships with key stakeholders, and familiarity with the sci-
entific literature. Large-scale policy studies by construct
require scientific expertise and objectivity that is provided
by non-political entities such as academic institutions.
However, academicians typically separate themselves
from the political arena and often find themselves work-
ing in a setting devoid of real-world context or experience
[20]. We argue that those involved in research ought to
cultivate familiarity with the policy environment and
build relationships with policy-makers and stakeholders.
Likewise, being armed with scientific background is a key
element in being prepared to recognize opportunities as
well as for planning and ultimately implementing policy
studies. As our experience shows, opportunity may alsoHealth Research Policy and Systems 2008, 6:5 http://www.health-policy-systems.com/content/6/1/5
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flow from financial impediments that prohibit large-scale
implementation of policies of interest.
Not surprisingly, we found that success requires a high
degree of multi-institutional collaboration, involving gov-
ernment entities and the private entrepreneurship of the
investigators. Our partnership involved disparate institu-
tions: the Philippines Department of Health, which has a
strong relationship as well as some rivalries with Phil-
Health, the National Insurance payer, and our two aca-
demic institutions. Our collaboration was not always
easy; however it was rooted in dedicated leadership com-
mitted to improving health and advancing research. Lead-
ership, we observed, also involved a significant level of
risk taking from both the policy makers and researchers
involved. For policy makers, there is risk in that the part-
nership or experiment might fail to materialize, be
funded, or be implemented. In QIDS, the Philippine gov-
ernment had to trust their academic counterparts, who
ultimately could not control the outcomes, and thus
risked their own political capital by sponsoring a study
that might uncover effects of government policy that were
not flattering or even become the source of eventual
embarrassment. From the perspective of the academic
leadership, the risks stem from the limited control of the
policy environment and the inability to create a stable set-
ting that is the usual basis for a scientific study. There is
additional professional risk associated with the opportu-
nity costs of pursuing an opportunity that may never
materialize, thus hurting chances for promotion or
advancement. Arguably, research funding for policy eval-
uation is harder to obtain, the costs typically are high and
there are legitimate concerns over the generizability of the
ultimate findings. Accordingly, given the risks involved,
the early dialog between the collaborating entities neces-
sitates understanding and trust between partners.
In our experience, tensions may arise when collaborating
entities that have varying levels of financial investment in
the study. Perhaps conflicts can be discouraged if costs are
shouldered equally or if a neutral outside source provides
the necessary financial resources, but this seems unlikely
to happen in the uncertain funding environments that
characterize competitive research. In the developing coun-
try setting in particular, co-funding is almost always nec-
essary to conduct these types of large-scale policy
experiments. To ensure scientific integrity, study funding
should come from donor agencies free of conflicts of
interest with participating entities. Securing these funds,
for example from the U.S. National Institutes of Health
(NIH), bestows legitimacy as well. The challenge is to suc-
ceed in the highly competitive environment, and a good
degree of luck is involved in this process. Ultimately, suc-
cess will be largely dependent on the ability to delineate
or distinguish between plan and implementation.
Researchers have thus proposed an International NIH to
overcome the challenges of finding funds for research in
less developed countries [29]. Lastly, as we described in
our Results, the funding stream must be timed with the
introduction of the interventions as well as data collec-
tion. Probably the only assurance would be to secure
funding ahead of formal approvals for the study, which
requires a great deal of work and perhaps serendipity on
the part of the investigators to coordinate.
Though partnerships and funding are the building blocks
of the policy study, a key finding from QIDS that might be
overlooked is the formalization and legalization of the
policy interventions into the existing health care system.
We find that this integration is required to maintain secu-
rity in what may be a highly uncertain or changing
bureaucratic environment. It is not untypical in develop-
ing countries that research endeavors fail due to shifts in
political parties, changes in agency heads, or economic
downturn [30]. We found that formal board resolutions
and signed legal documents protected us against unfore-
seen events.
With agreements in place, randomizing communities is
another achievable step in the policy experiment; so is
introducing a control arm. Voluntary participation is not
only a cornerstone of research, but essential in a policy
environment that will likely become even more complex
once the study is underway. Randomizing populations to
interventions is always contentious, particularly in an
intervention-control design where some communities
will 'not get something'. We anticipated and certainly
experienced reluctance at the district level to randomiza-
tion to the control arm, mainly by hospital directors. We
ultimately overcame this hurdle by describing the control
arm to participants as part of ongoing change justifiable
given the introduction of other policies in an environ-
ment that was not strategically or operationally static in
the long term. Our discussions at the local, provincial and
national levels explaining the design ex ante were key in
QIDS.
Another important lesson is to carefully choose interven-
tions so that they are relevant, implementable, and can
eventually be scaled-up for large-scale introduction.
Because the HSRA goals were rather broad, we decided to
introduce specific policies that could be later be easily
introduced at the national level by the DOH and Phil-
Health. Deciding the details of these interventions
required us to have a good deal of knowledge regarding
PhilHealth's capabilities and capacity for policy change.
Through communications with PhilHealth, it was
decided that we would focus on children under six years
of age, where we were likely to see the greatest impact in
the shortest time frame and in a population that wouldHealth Research Policy and Systems 2008, 6:5 http://www.health-policy-systems.com/content/6/1/5
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receive the greatest amount of political support. How-
ever, a criterion set by PhilHealth was that a child must
be a dependent of a PhilHealth member in order to take
advantage of expanded insurance benefits. Thus, we felt it
was necessary, as part of this intervention for QIDS to
take additional measures to enroll entire families into
PhilHealth and set goals for enrolling a certain number of
families. These goals were individualized with each
mayor and then formal arrangements were put in place to
achieve them. This strategy demonstrated to be cost-effec-
tive at $0.86 USD per enrollee, making it an inexpensive
yet effective approach that can be scaled-up by Phil-
Health [31].
Similarly, we designed our Bonus Intervention in a way
that could also be easily expanded by PhilHealth. This
intervention introduced a performance-based payment
scheme for hospitals and physicians based on a quality of
care performance measure which we refer to as Q*, a met-
ric that measures clinical performance, patient satisfaction
and volume of physician services. We found that the Q*
measure was readily introduced into our 30 different
study sites distributed over a wide-geographic and dispa-
rate-cultural area, largely because data collection did not
require a great deal of marginal resources [15]. Data on
Q* component indicators are collected through three
straightforward mechanisms. The clear transparency of
the measurement and issuances based on Q* through the
notification of provincial governors, hospital directors
and physicians proved to enhance credibility and support
for the data collection. This measure is now used for inter-
nal monitoring and to evaluate new approaches for
improving performance. As Q* measurements are tied to
bonus payments to the hospitals, it has also given the met-
ric meaning and consequence. As with enrollment, the
quality measurement has proven to be inexpensive and
implementable, thus making it more likely to be
expanded at the national level.
We believe that comprehensive data collection is critical
to informing large-scale policy changes. Beyond the obvi-
ous, which is the need to collect data to evaluate the effi-
cacy of the policies and the demonstration that multilevel
data can be collected around a policy evaluation, there are
other benefits of comprehensive data collection. First,
there may be unexpected findings. In the QIDS study so
far we have found a high prevalence of elevated blood
lead levels among children that was previously unknown,
unexpected prescribing practices among physicians, and a
negative impact of extra budgetary insurance funding for
the poor [31-33]. Second, with the public release of the
data, there now exists a substantial learning opportunities
around such a rich data set for other investigators in the
Philippines and internationally. The data has attracted a
number of investigators and continues to draw more.
Perhaps, most importantly, QIDS data has given rise to a
deeper commitment to the health sector reform agenda.
And it has informed policy-making in real-time. While
health policy by its very nature is dynamic, research, by
contrast, is slow to provide real time guidance to policy
makers [34]. To surmount this, we partnered QIDS with
governmental policy monitoring and evaluation
(referred to as ME3), developed policy briefs and other
activities to integrate research in a time-conscious man-
ner. Monitoring and evaluation systematically monitors
the progress towards targets and evaluation of policy out-
comes within the policy cycle, which are key components
of evidence-based policy making [28]. It has gained atten-
tion as a means to enhance sound governance by provid-
ing input into decision-making, including the budget
process, providing information to support evidence-
based policy discussions, and for understanding perform-
ance, critical for learning, planning and growth [35].
ME3, using QIDS methodology and data, will form the
basis for real-time guidance to the Secretary of Health in
assessments of how the health reform policies benefit the
Filipino people.
Limitations
There are a number of study limitations that warrant men-
tion here. The first is that we are challenged by the study
size in our hierarchically-designed study in three ways:
While we were able to include a large sample of children
in the study, we would have liked to include more com-
munities and thus improved our overall sample size. With
a larger number of units to randomize, we would be able
to better assess policy impacts in differing settings and to
have larger power in our statistical analyses. Similarly,
while we were able to include a random household sam-
ple at our baseline assessment, we did not have the finan-
cial resources to conduct a second random household
survey during the second round of data collection. Lastly,
while we are able to follow our screened-in children and
facilities as a whole over time and create a panel data set,
our other data, such as physician vignettes, are obtained
through serial cross-sections conducted every six months.
This makes it difficult to follow specific providers over
time and to link providers with children except at the facil-
ity level.
Lastly, although we have regularly communicated our
results with key stakeholders and partners, for example
PhilHealth, we are limited by their absorptive capacity to
translate the results into timely action. This is perhaps best
exemplified in our serendipitous finding of a lead epi-
demic among children in the Visayas–although our find-
ings have been well communicated with department
heads at the Department of Health, PhilHealth, and local
health organizations, little action has been taken to deal
with this problem.Health Research Policy and Systems 2008, 6:5 http://www.health-policy-systems.com/content/6/1/5
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Conclusion
One of the biggest challenges to evidence-based policy
making is balancing scientific evidence with context. The
policy environment is slanted away from evidence and
toward context or the social milieu, driven largely by
financial constraints [34]. Apart from this, policy-makers
often rely heavily on personal experience, local informa-
tion, expert opinions, and pressure from advocates [36].
Clearly, policy made devoid of context runs the risk of fail-
ure. However, it is possible that there is a balance between
evidence and context [34]. One of the ways to achieve this
balance is by bringing together science with policy-mak-
ing and engaging researchers and decision-makers in the
study process. QIDS shows that evidence-based policy
making done in conjunction with the goals and objectives
of the governmental reform agenda can marry science
with context.
As we have described, through collaboration with govern-
ment decision-makers a large, prospective, randomized
controlled policy experiment was successfully imple-
mented at the national level as part of sectoral reform.
While we believe policy experiments such as this can be
used to inform health policy, our experience highlights
the importance of key factors in success: being opportun-
istic, building strong collaborative relationships, timing
the policy interventions with data collection, providing
real-time feedback to policymakers during the course of
the study, and integrating the study into the existing deliv-
ery of care infrastructure.
QIDS nurtures the growing attitude that translation of sci-
entific findings from the bedside to the community can be
done successfully and raises the bar on project evaluation
and the policy-making process.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
RS participated in the conceptualization and drafting of
this manuscript. JP was involved in the conception of the
study and in the conceptualization and drafting of this
manuscript. SQ participated in the study and helped draft
the manuscript. OS was involved in the conception of the
study and the drafting parts of this manuscript. All authors
have read and approved the final manuscript.
Acknowledgements
The Quality Improvement Demonstration Study is funded by the U.S. 
National Institutes for Child Health and Human Development through an 
R01 grant (HD042117).
References
1. Macintyre S, Chalmers I, Horton R, Smith R: Using evidence to
inform health policy: Case study.  BMJ 2001, 322:222-225.
2. Thomson H, Hoskins R, Petticrew M, Ogilvie D, Craig N, Quinn T,
Lindsay G: Evaluating the health effects of social interven-
tions.  BMJ 2004, 328:282-285.
3. Dunn W: Public Policy Analysis: An Introduction.  New Jersey
, Pearson Prentice Hall; 2004. 
4. Frenk J: Balancing relevance and excellence: Organizational
responses to link research with decision making.  Soc Sci Med
1992, 35(11):1397-1404.
5. Niessen LW, Grijseels EW, Rutten FF: The evidence-based
approach in health policy and health care delivery.  Soc Sci Med
2000, 51(6):859-869.
6. Klein R: From evidence-based medicine to evidence-based
policy?  J Health Serv Res Policy 2006, 5:65-66.
7. Harries U, Elliott H, Higgins A: Evidence-based policy-making in
the NHS: Exploring the interface between research and the
commissioning process.  J Public Health Med 1999, 21:29-36.
8. Obermann K, Jowett MR, Alcantara MO, Banzon EP, Bodart C:
Social health insurance in a developing country: the case of
the Philippines.  Soc Sci Med 2006, 62(12):3177-3185.
9. Philippines Department of Health: National Objectives for
Health, Philippines, 1999-2004.  Manila, Philippines , Department
of Health; 1999. 
10. Food and Agriculture Organization of the United Nations: National
sectoral report for the Philippines - Women, agriculture and
rural development.  Rome, Italy , Food and Agriculture Organiza-
tion of the United Nations; 1995. 
11. Philippine National Statistical Coordination Board: Philippine Sta-
tistical Yearbook.  Manila, Philippines , Philippine National Statisti-
cal Coordination Board; 2005. 
12. Philippines Department of Health: The 2003 National Demo-
graphic and Health Survey.  Manila, Philippines , Department of
Health; 2003. 
13. World Health Organization: World Health Statistics 2006.
Geneva, Switzerland , The World Health Organization; 2006. 
14. Philippines Department of Health: Philippines National Nutrition
Survey.  Manila, Philippines , Department of Health; 2003. 
15. Solon O, Woo K, Quimbo SA, Shimkhada R, Florentino J, Peabody
JW: A novel method for measuring health care system per-
formance: Experience from QIDS in the Philippines.  Manu-
script submitted for publication 2008.
16. Davies P: Policy Evaluation in the United Kingdom.  In KDI Inter-
national Policy Evaluation Forum Seoul, Korea ; 2004. 
17. Dresselhaus TR, Peabody JW, Luck J, Bertenthal D: An evaluation
of vignettes for predicting variation in the quality of preven-
tive care.  J Gen Intern Med 2004, 19(10):1013-1018.
18. Peabody JW, Luck J, Glassman P, Dresselhaus TR, Lee M: Compari-
son of vignettes standardized patients and chart abstraction
- A prospective validation study of 3 methods for measuring
quality.  JAMA 2000, 283(13):1715-1722.
19. Peabody JW, Luck J, Glassman P, Jain S, Hansen J, Spell M, Lee M:
Measuring the quality of physician practice by using clinical
vignettes: A prospective validation study.  Ann Intern Med 2004,
141(10):771-780.
20. Trostle J, Bronfman M, Langer A: How do researchers influence
decision-makers? Case studies of Mexican policies.  Health Pol-
icy Plan 1999, 14:103-114.
21. Quality Improvement Demonstration Study : Quality Improve-
ment Demonstration Study .   [http://www.qids.ph].
22. Leatherman S, Sutherland K: Designing national quality reforms:
a framework for action.  Int J Qual Health Care 2007,
19(6):334-340.
23. Cole BL, Shimkhada R, Fielding JE, Kominski G, Morgenstern H:
Methodologies for realizing the potential of health impact
assessment.  Am J Prev Med 2005, 28(4):382-389.
24. Sterman JD: Learning from evidence in a complex world.  Am J
Public Health 2006, 96:505-514.
25. Joffe M, Mindell JS: Complex causal process diagrams for ana-
lyzing the health impacts of policy interventions.  Am J Public
Health 2006, 96(3):473-479.
26. Levine R, Kinder M: Millions Saved: Proven Successes in Global
Health.  Washington D.C. , Center for Global Development; 2004. Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Health Research Policy and Systems 2008, 6:5 http://www.health-policy-systems.com/content/6/1/5
Page 12 of 12
(page number not for citation purposes)
27. Gertler PJ: Do conditional cash transfers improve child health?
Evidence from PROGRESA's control randomized experi-
ment.  Am Econ Rev 2004, 94(2):336-341.
28. Mackay K: Institutionalization of Monitoring and Evaluation
Systems to Improve Public Sector Management. Independ-
ent Evaluation Group ECD working paper No.15.  Washing-
ton, D.C. , Independent Evaluation Group, The World Bank; 2006. 
29. Feachem RGA, Sachs JD: Global Public Goods for Health:
Report of Working Group 2 of the Commission on Macr-
oeconomics and Health.  Geneva, Switzerland , World Health
Organization; 2002. 
30. Sparks BL, Gupta SK: Research in family medicine in developing
countries.  Ann Fam Med 2004, 26(Suppl 2):S55-9.
31. Solon O, Peabody JW, Woo K, Quimbo SA, Florentino J, Shimkhada
R:  A cost-effective approach to improving access to care
using policy navigators.  Manuscript submitted for publication 2008.
32. James C: Studies of Philippine public district hospitals and pri-
vate pharmacies.   London School of Tropical Medicine and
Hygiene; 2008. 
33. Riddell T, Solon O, Quimbo S, Tan C, Butrick E, Peabody JW: Ele-
vated blood-lead levels among children living in the rural
Philippines.  Bull World Health Organ 2007, 85(9):649-732.
34. Dobrow MJ, Goel V, Upshur REG: Evidence-based health policy:
Context and utilisation.  Soc Sci Med 2004, 58:207-217.
35. World Bank: Chile: Study of Evaluation Program  Impact Eval-
uation and Evaluations of Government Programs.  Washing-
ton D.C. , The World Bank; 2005. 
36. Black N: Evidence based policy: proceed with care.  BMJ 2001,
323 :275-278.